Frequencies for first 10,000 rows of dose_vbm variable in drug2007q4 dataset : Verbatim text for dose, frequency, and | route, exactly as entered on report | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 7,521 75.21 75.21 (0.3 ML SUBCUTANEOUS, (0.4 ML PRN SUB.. | 1 0.01 75.22 (1 DF QD EZETIMIBE (10 MG) + SIMVASTA.. | 1 0.01 75.23 (10 MG BID ORAL) | 1 0.01 75.24 (100 MG QD ORAL) | 1 0.01 75.25 (100 MG TID ORAL) | 1 0.01 75.26 (160 MG QD ORAL), (160 MG QD ORAL), (.. | 1 0.01 75.27 (2 IN 1 D), ORAL | 1 0.01 75.28 (20 MG), SUBCUTANEOUS | 1 0.01 75.29 (200 MG) | 1 0.01 75.30 (200 MG, 1-3 TIMES) | 1 0.01 75.31 (3 MG 4X/WEEK), (5 MG 3X/WEEK) | 1 0.01 75.32 (300 MG QD ORAL) | 1 0.01 75.33 (40 MG BID), (40 MG QD) | 1 0.01 75.34 (7.5 MG, 1 DOSE QD PRN) | 1 0.01 75.35 (DF) | 1 0.01 75.36 (ORAL) | 5 0.05 75.41 .088 MG, UNK | 1 0.01 75.42 .112 UNK, QD MON-SAT | 1 0.01 75.43 .125 UNK, QW SUNDAY | 1 0.01 75.44 .125MG PER DAY | 1 0.01 75.45 .25 MG, PRN | 1 0.01 75.46 .25MCG PER DAY | 1 0.01 75.47 .25MG PER DAY | 2 0.02 75.49 .25MG UNKNOWN | 1 0.01 75.50 .25MG, UNK | 1 0.01 75.51 .2MG/HR | 1 0.01 75.52 .2ML PER DAY | 1 0.01 75.53 .4G SINGLE DOSE | 1 0.01 75.54 .4MG PER DAY | 1 0.01 75.55 .4ML PER DAY | 1 0.01 75.56 .5 GRAM, DAILY | 2 0.02 75.58 .5 MG, TID | 1 0.01 75.59 .5G PER DAY | 1 0.01 75.60 .5MCG PER DAY | 1 0.01 75.61 .5MG AT NIGHT | 1 0.01 75.62 .5MG PER DAY | 3 0.03 75.65 .5MG UNKNOWN | 1 0.01 75.66 .5TAB PER DAY | 1 0.01 75.67 .625 MG, QD | 1 0.01 75.68 .6MG PER DAY | 1 0.01 75.69 .7 G, UNK | 1 0.01 75.70 .8 G, UNK | 1 0.01 75.71 0,5 ML, EVERY 2D | 1 0.01 75.72 0-8 UNITS/HR | 1 0.01 75.73 0.05 MG, QD | 1 0.01 75.74 0.05 MG, UNK | 1 0.01 75.75 0.05 ML, UNK | 3 0.03 75.78 0.1 MG, 2/D | 1 0.01 75.79 0.1 ML AS NEEDED ID | 1 0.01 75.80 0.2 MG, QD | 1 0.01 75.81 0.2 MG, TID | 1 0.01 75.82 0.25 MG, QD | 1 0.01 75.83 0.25 TSP, ONCE/SINGLE, ORAL | 1 0.01 75.84 0.4 MG, QD | 1 0.01 75.85 0.4 MG, UNK | 1 0.01 75.86 0.5 DF, QD | 1 0.01 75.87 0.5 MG TID PRN | 1 0.01 75.88 0.5 MG, 1/MONTH | 1 0.01 75.89 0.5 MG, 2/D | 1 0.01 75.90 0.5 MG, 3/D | 1 0.01 75.91 0.5 MG, OTHER | 1 0.01 75.92 0.5 MG, Q4W | 1 0.01 75.93 0.5 MG, QD | 4 0.04 75.97 0.5 MG, TID | 1 0.01 75.98 0.5 MG, UNK | 2 0.02 76.00 0.5 MG-1.0 MG, ORAL | 1 0.01 76.01 0.5 MG/DAY | 1 0.01 76.02 0.5 MG; UNSPECIFIED FREQUENCY | 1 0.01 76.03 0.5-1MG/DAY PRN | 1 0.01 76.04 0.625 MG | 1 0.01 76.05 0.625 MG/ 5 MG | 1 0.01 76.06 0.625 MG/2.5 MG | 1 0.01 76.07 0.625 MG/5 MG | 1 0.01 76.08 0.75 MG, BID | 1 0.01 76.09 0.8 MG, OTHER | 1 0.01 76.10 0.9 MG | 1 0.01 76.11 05 FEBRUARY 2001: NOTED PATIENT IS ON.. | 1 0.01 76.12 1 A DAY | 1 0.01 76.13 1 APPLICATION 1 TIME A WEEK TOPICAL | 1 0.01 76.14 1 APPLICATION TOPICAL | 1 0.01 76.15 1 CAPS, UNK | 1 0.01 76.16 1 CAPSULE, QHS | 1 0.01 76.17 1 DF, BID | 3 0.03 76.20 1 DF, QD | 7 0.07 76.27 1 DF, QW | 1 0.01 76.28 1 DF, SINGLE | 2 0.02 76.30 1 DF, UNK | 1 0.01 76.31 1 DF; PO | 1 0.01 76.32 1 DOSAGE FORM=58GY. HAD TOTAL OF 36GY.. | 1 0.01 76.33 1 DOSE EACH 28 DAYS | 1 0.01 76.34 1 G, DAYS 1+15 | 1 0.01 76.35 1 G, QD | 2 0.02 76.37 1 G, UNK | 2 0.02 76.39 1 G/DAY | 1 0.01 76.40 1 G/H OVER 24 H | 1 0.01 76.41 1 G/KG, UNK | 1 0.01 76.42 1 MG | 1 0.01 76.43 1 MG, ONCE/SINGLE | 1 0.01 76.44 1 MG, PRN | 1 0.01 76.45 1 MG, QD | 3 0.03 76.48 1 MG, TID | 1 0.01 76.49 1 MG, UNK | 2 0.02 76.51 1 MG/H | 1 0.01 76.52 1 PATCH/DAY | 1 0.01 76.53 1 PILL EVERY 12 HOURS PO | 1 0.01 76.54 1 STRIP 1 TIME, ORAL | 1 0.01 76.55 1 TAB(S), 1X/DAY | 7 0.07 76.62 1 TAB(S), 21D/28D | 2 0.02 76.64 1 TABLET | 1 0.01 76.65 1 TABLET DAILY | 1 0.01 76.66 1 TABLET EVERY 12 HOUR (2 IN 1 D),ORAL | 1 0.01 76.67 1 TABLET PO TID PRN | 1 0.01 76.68 1 TABLET, PRN | 2 0.02 76.70 1 TABLET, Q8H | 1 0.01 76.71 1 TABLET/DAY | 1 0.01 76.72 1 UNK, 2/D | 1 0.01 76.73 1 UNK, UNK | 1 0.01 76.74 1,575 AT LEAST UP TO JAN-2004 | 1 0.01 76.75 1-2 Q4-6 HOURS PRN | 1 0.01 76.76 1.00 MG/M2, INTRAVENOUS | 1 0.01 76.77 1.1/2 GM, QD | 1 0.01 76.78 1.21MG AS DIRECTED | 1 0.01 76.79 1.21MG PER DAY | 1 0.01 76.80 1.25 MG | 1 0.01 76.81 1.25 MG QD; PO | 1 0.01 76.82 1.25 MG, QD | 2 0.02 76.84 1.25 MG, UNK | 2 0.02 76.86 1.44 G/DAY | 3 0.03 76.89 1.5 AUC WEEKLY IV BOLUS | 1 0.01 76.90 1.5 MG, BID | 1 0.01 76.91 1.5 MG, DAILY (1/D) | 1 0.01 76.92 1.5 MG, Q72H, TRANSDERMAL | 1 0.01 76.93 1.5 MG/D | 4 0.04 76.97 1.5 MG/KG | 1 0.01 76.98 1.5 TSP, QD FOR 2 MONTHS, ORAL | 1 0.01 76.99 1.5G THREE TIMES PER DAY | 1 0.01 77.00 1.5MG PER DAY | 1 0.01 77.01 1.5MGM2 CYCLIC | 1 0.01 77.02 1.6 G 2/D IVI | 1 0.01 77.03 1.6 MG, INTRAVENOUS | 1 0.01 77.04 1.7 ML, ONCE/SINGLE | 2 0.02 77.06 1.75 MG, DAILY (1/D) | 1 0.01 77.07 1.8 MG, DAILY (1/D) | 1 0.01 77.08 1.8 ML, ONCE/SINGLE | 1 0.01 77.09 1/2 10 MG TABLET | 1 0.01 77.10 1/2 100 MG QD | 1 0.01 77.11 1/2 TABLET | 1 0.01 77.12 1/2 TABLET DAILY | 1 0.01 77.13 10 1/DAY PO | 1 0.01 77.14 10 COURSES | 2 0.02 77.16 10 IU, EACH EVENING | 1 0.01 77.17 10 MEQ, BID | 2 0.02 77.19 10 MG | 2 0.02 77.21 10 MG / DAY | 1 0.01 77.22 10 MG BENA/12.5 MG HCT, UNK | 1 0.01 77.23 10 MG BID PO | 1 0.01 77.24 10 MG PRN ORAL | 1 0.01 77.25 10 MG QD PO | 4 0.04 77.29 10 MG QD; PO | 1 0.01 77.30 10 MG, 1X/DAY:QD, TRANSDERMAL | 1 0.01 77.31 10 MG, 1X/DAY; QD, TRANSDERMAL; 15 MG.. | 1 0.01 77.32 10 MG, 2 IN 1 D, ORAL | 1 0.01 77.33 10 MG, 2/D | 1 0.01 77.34 10 MG, 3/D | 1 0.01 77.35 10 MG, BID | 4 0.04 77.39 10 MG, DAILY | 1 0.01 77.40 10 MG, DAILY (1/D) | 11 0.11 77.51 10 MG, DAILY, ORAL | 1 0.01 77.52 10 MG, EACH EVENING | 2 0.02 77.54 10 MG, EACH MORNING | 1 0.01 77.55 10 MG, HS | 1 0.01 77.56 10 MG, PRN | 5 0.05 77.61 10 MG, PRN, ORAL | 1 0.01 77.62 10 MG, QD | 8 0.08 77.70 10 MG, QD IN AM | 1 0.01 77.71 10 MG, QD IN PM | 1 0.01 77.72 10 MG, QD, HS | 1 0.01 77.73 10 MG, QHS | 10 0.10 77.83 10 MG, SINGLE | 3 0.03 77.86 10 MG, TID | 1 0.01 77.87 10 MG, UNK | 6 0.06 77.93 10 MG, UNKNOWN | 1 0.01 77.94 10 MG/D | 4 0.04 77.98 10 MG/D, UNK | 1 0.01 77.99 10 MG/M2, UNK | 1 0.01 78.00 10 MG; PO | 1 0.01 78.01 10 MIU; TIW; SC | 1 0.01 78.02 10 ML, EVERY 4 HOURS PRN | 1 0.01 78.03 10 U, 2/D | 1 0.01 78.04 10 U, EACH EVENING | 1 0.01 78.05 10 UG, 2/D | 15 0.15 78.20 10 UG, 2/D, SUBCUTANEOUS, 5 UG, 2/D, .. | 1 0.01 78.21 10 UG, 2/D, SUBCUTANEOUS; 5 UG, 2/D, .. | 1 0.01 78.22 10 UG, EACH EVENING | 1 0.01 78.23 10 UG, SUBCUTANEOUS | 1 0.01 78.24 10 UG, SUBCUTANEOUS; 5UG, SUBCUTANEOUS | 1 0.01 78.25 10 UG, UNKNOWN | 2 0.02 78.27 10/20 | 1 0.01 78.28 10/20 MG, QD | 1 0.01 78.29 10/20, QD | 1 0.01 78.30 10/40MG | 1 0.01 78.31 100 A?G, QD | 1 0.01 78.32 100 MCG, DAILY, INTRATHECAL | 1 0.01 78.33 100 MG QD ORAL | 1 0.01 78.34 100 MG QD; PO | 1 0.01 78.35 100 MG QD;PO | 1 0.01 78.36 100 MG, 2/D | 1 0.01 78.37 100 MG, 5QD | 2 0.02 78.39 100 MG, BID | 2 0.02 78.41 100 MG, DAILY | 1 0.01 78.42 100 MG, DAYS 1+15 | 1 0.01 78.43 100 MG, PRN | 1 0.01 78.44 100 MG, QD | 7 0.07 78.51 100 MG, TID | 4 0.04 78.55 100 MG, UNK | 2 0.02 78.57 100 MG/D | 3 0.03 78.60 100 MG/M2, DAY 2 EVERY 2 WEEKS | 1 0.01 78.61 100 UG, QD | 1 0.01 78.62 100/400 | 1 0.01 78.63 100/850 MG/DAILY | 1 0.01 78.64 1000 MG + 800 UI | 1 0.01 78.65 1000 MG 2/D PO | 1 0.01 78.66 1000 MG DAILY | 1 0.01 78.67 1000 MG, 2/D | 2 0.02 78.69 1000 MG, EACH MORNING | 1 0.01 78.70 1000 MG, ONCE/SINGLE | 1 0.01 78.71 1000 MG, PRN | 1 0.01 78.72 1000 MG, QD | 3 0.03 78.75 1000 MG, QD; PO | 1 0.01 78.76 1000 MG, UNK | 1 0.01 78.77 1000 MG/DAY | 2 0.02 78.79 1000 MG/M2, DAY 2 EVERY 2 WEEKS | 1 0.01 78.80 1000 MG; QD; PO | 1 0.01 78.81 1000 ML, AT ONCE | 1 0.01 78.82 1000 UG, EVERY 4 HOURS PRN | 1 0.01 78.83 100000 UNK, BID | 1 0.01 78.84 1000MG PER DAY | 4 0.04 78.88 1000MG SINGLE DOSE | 1 0.01 78.89 1000MG THREE TIMES PER DAY | 6 0.06 78.95 1000MG TWICE PER DAY | 1 0.01 78.96 1000MGM2 PER DAY | 1 0.01 78.97 1004MG TWICE PER DAY | 1 0.01 78.98 100MG | 1 0.01 78.99 100MG DAILY PO | 1 0.01 79.00 100MG AS DIRECTED | 1 0.01 79.01 100MG AS REQUIRED | 1 0.01 79.02 100MG PER DAY | 11 0.11 79.13 100MG TWICE PER DAY | 2 0.02 79.15 100MG UNKNOWN | 1 0.01 79.16 100UG/HR AND 25UG/HR | 1 0.01 79.17 104 MG (104 MG, 1ST INJECTION), SUBCU.. | 1 0.01 79.18 104 MG (104 MG, LAST INJECTION), SUBC.. | 1 0.01 79.19 10MCG PER DAY | 1 0.01 79.20 10MG / 2 ML | 1 0.01 79.21 10MG AS REQUIRED | 1 0.01 79.22 10MG AT NIGHT | 1 0.01 79.23 10MG PER DAY | 12 0.12 79.35 10MG TWICE PER DAY | 3 0.03 79.38 110MCG TWICE PER DAY | 1 0.01 79.39 110MGM2 CYCLIC | 1 0.01 79.40 1125 MG, QD | 1 0.01 79.41 1196 MG, Q2W | 1 0.01 79.42 12 IU MORNING, 10 IU NOON, 10 IU EVEN.. | 1 0.01 79.43 12 MG, DAILY, ORAL | 1 0.01 79.44 12 ML, 1 DOSE | 1 0.01 79.45 12 U, EACH EVENING | 1 0.01 79.46 12 U, PER DAY | 1 0.01 79.47 12+8 IU | 1 0.01 79.48 12.5 MG | 1 0.01 79.49 12.5 MG, EACH EVENING | 1 0.01 79.50 12.5 MG, QHS | 2 0.02 79.52 12.5 MG, UNK | 1 0.01 79.53 12.5MG TWICE PER DAY | 1 0.01 79.54 12.5MG, UNK | 1 0.01 79.55 120 MCG SQ BID | 1 0.01 79.56 120 MCG; QW; SC | 1 0.01 79.57 120 MG / DAY | 1 0.01 79.58 120 MG, BID | 2 0.02 79.60 120 MG, DAILY (1/D) | 1 0.01 79.61 120 MG, QD | 2 0.02 79.63 120 MG/DAY | 1 0.01 79.64 1200 MG, DAILY (1/D) | 1 0.01 79.65 1200 MG, PRN | 1 0.01 79.66 1200 MG, QD | 1 0.01 79.67 1200 MG; QD; PO | 1 0.01 79.68 1200 UNITS Q2WKS IV | 1 0.01 79.69 1200/1600 MG BLINDED THERAPY | 1 0.01 79.70 120MG PER DAY | 1 0.01 79.71 120MG THREE TIMES PER DAY | 1 0.01 79.72 120MG/D | 1 0.01 79.73 1210 MG, UNK | 1 0.01 79.74 1230 MG, Q3W | 1 0.01 79.75 125 A?G, QD | 1 0.01 79.76 125 MCG/H, | 1 0.01 79.77 125 MG/M2; IV, 125 MG/M2; IV | 1 0.01 79.78 1250 MG, QD | 1 0.01 79.79 1250MG PER DAY | 3 0.03 79.82 12G/M2 OVER 4 HRS | 1 0.01 79.83 12GUM PER DAY | 1 0.01 79.84 12GY PER DAY | 1 0.01 79.85 12MG PER DAY | 1 0.01 79.86 13.8 MG;XI, IV, 39.6 MG,XI, IV | 1 0.01 79.87 130 MG, DAILY, ORAL | 1 0.01 79.88 132 MG, UNK | 1 0.01 79.89 1360 MG ADMINISTERED ON 20-JUL-2007. | 1 0.01 79.90 1375 MG, QD | 1 0.01 79.91 14 U, UNK | 1 0.01 79.92 140 MG, QD | 1 0.01 79.93 1400 MG DAILY | 1 0.01 79.94 15 IU, QD | 1 0.01 79.95 15 MG AS NEEDED FOR SLEEP | 1 0.01 79.96 15 MG ORAL | 1 0.01 79.97 15 MG QD; PO | 1 0.01 79.98 15 MG, BID | 2 0.02 80.00 15 MG, DAILY | 1 0.01 80.01 15 MG, DAILY (1/D) | 4 0.04 80.05 15 MG, EACH EVENING | 1 0.01 80.06 15 MG, QID | 1 0.01 80.07 15 MG, UNK | 2 0.02 80.09 15 MG, UNKNOWN | 1 0.01 80.10 15 MG/D | 2 0.02 80.12 15 MG/DAY | 2 0.02 80.14 15 MG/KG, Q2W | 1 0.01 80.15 15 MG/KG, Q3W | 1 0.01 80.16 15 MG/KG, UNK | 1 0.01 80.17 15 MG; UNSPECIFIED FREQUENCY | 1 0.01 80.18 15 MIU, 3X/WEEK | 2 0.02 80.20 15 UG; QD; IM | 1 0.01 80.21 15 UG; QD; SC | 1 0.01 80.22 150 MCG/H | 1 0.01 80.23 150 MCG; QW; SC | 1 0.01 80.24 150 MG | 1 0.01 80.25 150 MG (Q3W), ORAL | 1 0.01 80.26 150 MG AM, 300 MG EVENING | 1 0.01 80.27 150 MG DAILY | 1 0.01 80.28 150 MG QD ORAL | 1 0.01 80.29 150 MG QD; PO | 1 0.01 80.30 150 MG TWICE A DAY ORAL | 1 0.01 80.31 150 MG, 1/MONTH | 1 0.01 80.32 150 MG, BID | 2 0.02 80.34 150 MG, FREQEUNCY UNKNOWN | 1 0.01 80.35 150 MG, Q2W | 1 0.01 80.36 150 MG, QD | 6 0.06 80.42 150 MG/DAY | 2 0.02 80.44 150 UNK, UNK | 1 0.01 80.45 1500 MG, DAILY, ORAL | 1 0.01 80.46 1500 MG, EACH EVENING | 1 0.01 80.47 1500 UG/DAY | 1 0.01 80.48 1500MG PER DAY | 4 0.04 80.52 1500MGM2 PER DAY | 1 0.01 80.53 150MG PER DAY | 8 0.08 80.61 150MG TWICE PER DAY | 1 0.01 80.62 150MG UNKNOWN | 1 0.01 80.63 150MG/DAY | 1 0.01 80.64 150TAB SINGLE DOSE | 1 0.01 80.65 152 MCG, DAILY, INTRATHECAL | 1 0.01 80.66 15MG AS REQUIRED | 1 0.01 80.67 15MG PER DAY | 3 0.03 80.70 15MG, ORAL | 1 0.01 80.71 15MG/D | 1 0.01 80.72 16 MG/DAY | 1 0.01 80.73 16 MIU, EVERY 2D | 1 0.01 80.74 16 U, EACH MORNING, | 1 0.01 80.75 16-JUL-07 39 MINUTES 17-JUL-07 7 MINU.. | 1 0.01 80.76 160 / 25 MG/DAY | 1 0.01 80.77 160 MG | 1 0.01 80.78 160 MG, Q12H | 1 0.01 80.79 160 MG, QD | 2 0.02 80.81 160MG PER DAY | 2 0.02 80.83 160MG THREE TIMES PER DAY | 1 0.01 80.84 160MG VAL/25MG HCT, QD | 1 0.01 80.85 160MG/25MG DAILY | 1 0.01 80.86 160MG/D | 1 0.01 80.87 160MGM2 CYCLIC | 1 0.01 80.88 168.8 MG IV | 2 0.02 80.90 17 G | 1 0.01 80.91 17 GM; BID; PO; 17 GM;QD; PO, 85 GM; .. | 1 0.01 80.92 17 INJECTIONS | 1 0.01 80.93 17.5 MG, 1/WEEK | 1 0.01 80.94 175 MG/DAY | 1 0.01 80.95 175MCG | 1 0.01 80.96 1760 MG, AT ONCE | 1 0.01 80.97 18 GTT, TID | 1 0.01 80.98 18 INFUSION ON UNSPECIFIED DATES. | 1 0.01 80.99 18 IU, EACH EVENING | 1 0.01 81.00 18 MG, DAILY (1/D) | 1 0.01 81.01 180 DF, ONCE/SINGLE | 1 0.01 81.02 180 MG | 1 0.01 81.03 180 MG, DAILY | 1 0.01 81.04 180 MG, QD | 1 0.01 81.05 180 MG, UNK | 1 0.01 81.06 1800 MG, AT ONCE | 1 0.01 81.07 1800 MG, QD | 1 0.01 81.08 1800 MG/DAY | 1 0.01 81.09 180TAB SINGLE DOSE | 1 0.01 81.10 18MG PER DAY | 1 0.01 81.11 18TSP SEE DOSAGE TEXT | 1 0.01 81.12 190 MG, 1/WEEK | 1 0.01 81.13 1980 MG, DAILY (1/D) | 1 0.01 81.14 1G SINGLE DOSE | 1 0.01 81.15 1G THREE TIMES PER DAY | 4 0.04 81.19 1G TWICE PER DAY | 2 0.02 81.21 1GM2 TWICE PER DAY | 1 0.01 81.22 1MG AS REQUIRED | 1 0.01 81.23 1MG PER DAY | 2 0.02 81.25 1MG THREE TIMES PER DAY | 1 0.01 81.26 1PUFF PER DAY | 2 0.02 81.28 1PUFF SINGLE DOSE | 1 0.01 81.29 1PUFF TWICE PER DAY | 3 0.03 81.32 1TAB PER DAY | 2 0.02 81.34 1TAB SEE DOSAGE TEXT | 1 0.01 81.35 1TAB TWICE PER DAY | 3 0.03 81.38 1U PER DAY | 1 0.01 81.39 2 CAPLETS AT BEDTIME 24 HOURS PO | 1 0.01 81.40 2 CAPSULES, QHS | 1 0.01 81.41 2 COURSES | 2 0.02 81.43 2 CYCLES | 2 0.02 81.45 2 DF, BID | 1 0.01 81.46 2 DF, QD | 1 0.01 81.47 2 DF/DAY | 1 0.01 81.48 2 G 2/D IVI | 1 0.01 81.49 2 G, TID | 1 0.01 81.50 2 INFUSIONS ON UNKNOWN DATES | 1 0.01 81.51 2 MG, 1X/DAY | 1 0.01 81.52 2 MG, BID | 2 0.02 81.54 2 MG, QD | 4 0.04 81.58 2 MG, QHS | 1 0.01 81.59 2 MG, QID | 1 0.01 81.60 2 MG, UNK | 1 0.01 81.61 2 MG/DAY | 1 0.01 81.62 2 MG/HR | 1 0.01 81.63 2 MG; HS; ORAL | 1 0.01 81.64 2 MIU, EVERY 2D | 1 0.01 81.65 2 MONTHLY | 1 0.01 81.66 2 PUFF, BID | 1 0.01 81.67 2 PUFF, PRN | 1 0.01 81.68 2 TABLETS DAILY | 1 0.01 81.69 2 TABLETS EVERY 4 HOURS PRN | 1 0.01 81.70 2 TABLETS, FREQUENCY UNKNOWN | 1 0.01 81.71 2 TID PRN | 1 0.01 81.72 2 WEEKS ON 1 WEEK PO | 1 0.01 81.73 2-3 PUFFS EVERY 4-6 HOURS AS NEEDED | 1 0.01 81.74 2.0 MG/DAILY | 1 0.01 81.75 2.01 GRAM, DAILY | 2 0.02 81.77 2.25 G TWICE A DAY IN EVENING HOURS | 2 0.02 81.79 2.4 MG, QW | 1 0.01 81.80 2.5 G/D | 1 0.01 81.81 2.5 MG | 1 0.01 81.82 2.5 MG EVERY 1 TRI | 1 0.01 81.83 2.5 MG QD; PO | 1 0.01 81.84 2.5 MG, DAILY (1/D) | 2 0.02 81.86 2.5 MG, QD | 3 0.03 81.89 2.5 MG, QHS | 1 0.01 81.90 2.5 MG, UNK | 2 0.02 81.92 2.5 MG, UNKNOWN | 2 0.02 81.94 2.5 MG/DAILY | 1 0.01 81.95 2.5MG PER DAY | 3 0.03 81.98 20 A?G/DAY, CONT | 6 0.06 82.04 20 MG | 1 0.01 82.05 20 MG (20 MG, 1 IN 1 D) | 1 0.01 82.06 20 MG (20 MG, 1 IN 1 D), SUBCUTANEOUS | 1 0.01 82.07 20 MG (20 MG,1 IN 1 D) | 1 0.01 82.08 20 MG ORAL | 1 0.01 82.09 20 MG TABLET 3 PER DAY PO | 1 0.01 82.10 20 MG, 1 IN D | 1 0.01 82.11 20 MG, 1X/DAY | 1 0.01 82.12 20 MG, 1X/DAY:QD; TRANSDERMAL | 1 0.01 82.13 20 MG, 2X/DAY | 1 0.01 82.14 20 MG, 30 MIN BEFORE MEALS | 1 0.01 82.15 20 MG, BID | 1 0.01 82.16 20 MG, DAILY (1/D) | 5 0.05 82.21 20 MG, DAYS 1-21, ORAL | 1 0.01 82.22 20 MG, INTRAVENOUS | 1 0.01 82.23 20 MG, PRN | 1 0.01 82.24 20 MG, PRN HS | 1 0.01 82.25 20 MG, PRN QWEEK | 1 0.01 82.26 20 MG, QD | 12 0.12 82.38 20 MG, QD, HS | 1 0.01 82.39 20 MG, QHS | 2 0.02 82.41 20 MG, SUBCUTANEOUS | 2 0.02 82.43 20 MG, TID | 1 0.01 82.44 20 MG, UNK | 12 0.12 82.56 20 MG, UNKNOWN | 3 0.03 82.59 20 MG/8 OZ, 1X, PO | 1 0.01 82.60 20 MG/D | 1 0.01 82.61 20 MG/DAY | 3 0.03 82.64 20 MG/M2 DAILY SC | 1 0.01 82.65 20 MG/M2 QD SC | 1 0.01 82.66 20 TABLETS (OVERDOSE AMOUNT 10000 MG) | 1 0.01 82.67 20 UG, DAILY (1/D) | 9 0.09 82.76 20 UG, UNK | 2 0.02 82.78 20 UNK, UNK | 1 0.01 82.79 20.18 MIU, UNK | 1 0.01 82.80 20/12.5 | 1 0.01 82.81 200 MCG, QD | 1 0.01 82.82 200 MCG/ML, DAILY, INTRATHECAL | 1 0.01 82.83 200 MG | 1 0.01 82.84 200 MG (100 MG, 2 IN 1 D) | 1 0.01 82.85 200 MG (200 MG, 1 IN 1 D) | 6 0.06 82.91 200 MG (200 MG, 1 IN 1 D) ORAL | 1 0.01 82.92 200 MG (200 MG,1 IN 1 D) | 1 0.01 82.93 200 MG BID ORAL | 1 0.01 82.94 200 MG IN AM AND 200MG/300 MG IN PM O.. | 1 0.01 82.95 200 MG QD; PO | 1 0.01 82.96 200 MG, 2X/DAY | 1 0.01 82.97 200 MG, BID | 2 0.02 82.99 200 MG, DAILY (1/D) | 1 0.01 83.00 200 MG, QD | 3 0.03 83.03 200 MG, QD, ORAL 400 MG, QD, ORAL | 1 0.01 83.04 200 MG, TID | 3 0.03 83.07 200 MG, UNK | 2 0.02 83.09 200 MG/D | 2 0.02 83.11 200 MG/D, UNK | 1 0.01 83.12 200 MG/DAY | 2 0.02 83.14 200 MG/M2; PO | 1 0.01 83.15 200/25 MG | 1 0.01 83.16 2000 MG / DAY | 1 0.01 83.17 200MG PER DAY | 5 0.05 83.22 200MG UNKNOWN | 2 0.02 83.24 200MG VARIABLE DOSE | 1 0.01 83.25 200MG/M**2; QD; PO; 75 MG/M**; QD; PO; | 1 0.01 83.26 20G PER DAY | 1 0.01 83.27 20MG EVERY 4 WEEKS | 1 0.01 83.28 20MG PER DAY | 11 0.11 83.39 20MG TABLET 3 PER DAY PO | 1 0.01 83.40 20MG TWICE PER DAY | 1 0.01 83.41 20MG UNKNOWN | 1 0.01 83.42 21 MG QD TRANSDERMAL | 1 0.01 83.43 21 U, EACH MORNING | 1 0.01 83.44 210 MG IV | 1 0.01 83.45 22 IU, EACH EVENING | 1 0.01 83.46 220 A?G, BID | 1 0.01 83.47 224 MCG, QD | 1 0.01 83.48 225 MG, BID | 2 0.02 83.50 225MG PER DAY | 1 0.01 83.51 24 IU, EACH MORNING | 1 0.01 83.52 24 MCG, BID, | 1 0.01 83.53 24 U, THREE TIMES DAILY | 1 0.01 83.54 24 UNITS, SINGLE | 1 0.01 83.55 245MG PER DAY | 1 0.01 83.56 24MG UNKNOWN | 1 0.01 83.57 25 MG | 1 0.01 83.58 25 MG ONE TIME DOSE | 1 0.01 83.59 25 MG ORAL | 1 0.01 83.60 25 MG QD ORAL | 1 0.01 83.61 25 MG X 2 CAPSULES | 1 0.01 83.62 25 MG, 1 IN 1 D, ORAL | 1 0.01 83.63 25 MG, 2/D | 1 0.01 83.64 25 MG, BID | 1 0.01 83.65 25 MG, DAILY (1/D) | 3 0.03 83.68 25 MG, DAY 1-21, ORAL, 25 MG/M2, ORAL | 1 0.01 83.69 25 MG, EACH EVENING | 1 0.01 83.70 25 MG, PRN | 1 0.01 83.71 25 MG, QD | 8 0.08 83.79 25 MG, QD, ORAL | 1 0.01 83.80 25 MG, QHS | 1 0.01 83.81 25 MG, UNK | 2 0.02 83.83 25 MG/D | 1 0.01 83.84 25 MG/DAY | 3 0.03 83.87 25 ML | 1 0.01 83.88 25 U, EACH EVENING | 1 0.01 83.89 25 U, EACH MORNING | 1 0.01 83.90 25 UG, QD | 1 0.01 83.91 250 / 50 | 1 0.01 83.92 250 MG / DAY | 1 0.01 83.93 250 MG DAILY | 1 0.01 83.94 250 MG, Q2W | 1 0.01 83.95 250 MG, QD | 2 0.02 83.97 250 MG, TID | 1 0.01 83.98 250 MG/D | 1 0.01 83.99 2500 MG, D1-14/Q3W | 1 0.01 84.00 2500MG PER DAY | 1 0.01 84.01 250MG/M2 WEEKLY IV BOLUS | 1 0.01 84.02 25G/DAY | 1 0.01 84.03 25MG PER DAY | 4 0.04 84.07 25MG TWICE DAILY | 1 0.01 84.08 25MG TWICE PER DAY | 2 0.02 84.10 26 UNITS AM/15 UNITS HS | 1 0.01 84.11 260 MG/KG, UNK | 1 0.01 84.12 273 MG IV | 1 0.01 84.13 2G/D | 1 0.01 84.14 2MEGU THREE TIMES PER DAY | 2 0.02 84.16 2MG ALTERNATING WITH 2.5 MG EVERY OT.. | 1 0.01 84.17 2MG AS REQUIRED | 1 0.01 84.18 2MG PER DAY | 4 0.04 84.22 2MG TWICE PER DAY | 2 0.02 84.24 2PUFF AS REQUIRED | 1 0.01 84.25 2PUFF PER DAY | 3 0.03 84.28 2PUFF TWICE PER DAY | 1 0.01 84.29 2TAB PER DAY | 5 0.05 84.34 2TAB SINGLE DOSE | 1 0.01 84.35 2TAB TWICE PER DAY | 1 0.01 84.36 3 CAP QHS PO | 1 0.01 84.37 3 COURSES | 1 0.01 84.38 3 DAYS PRIOR TO ADMISSION | 1 0.01 84.39 3 DOSES | 2 0.02 84.41 3 DOSES OF 5MG/KG | 1 0.01 84.42 3 G, UNK | 1 0.01 84.43 3 G/D | 1 0.01 84.44 3 GTT, BID | 1 0.01 84.45 3 INFUSIONS | 1 0.01 84.46 3 MG, BID | 1 0.01 84.47 3 MG, QHS | 3 0.03 84.50 3 MG, SINGLE | 2 0.02 84.52 3 MG, UNK | 2 0.02 84.54 3 MG/D | 4 0.04 84.58 3 MG/DAY | 1 0.01 84.59 3 MG/H | 1 0.01 84.60 3 PER DAY | 2 0.02 84.62 3 TABS/D | 1 0.01 84.63 3 TWICE DAILY; ON HOLD | 1 0.01 84.64 3.375 G, UNKNOWN FREQUENCY | 1 0.01 84.65 3.5 ML, BID | 1 0.01 84.66 3.6 MG, QMO | 1 0.01 84.67 3.6 MG/DAY | 1 0.01 84.68 3.75 MG, QMO | 1 0.01 84.69 3.75 MG, SINGLE, INTRAMUSCULAR | 1 0.01 84.70 30 COUNT BOTTLE | 2 0.02 84.72 30 DROPS/DAY | 1 0.01 84.73 30 MCG TID SC ; 60 MCG QID SC ; 15 MC.. | 1 0.01 84.74 30 MG | 1 0.01 84.75 30 MG (1 IN 1 D) ORAL; DOSE REDUCED O.. | 1 0.01 84.76 30 MG (30 MG, 1D); 15 MG (15 MG, 1 D).. | 1 0.01 84.77 30 MG ORAL, 45 MG ORAL, ORAL | 1 0.01 84.78 30 MG QD ORAL | 1 0.01 84.79 30 MG, INTRAMUSCULARLY EVERY 3-4 MON.. | 1 0.01 84.80 30 MG, 1/WEEK | 1 0.01 84.81 30 MG, 1X.DAY:QD, TRANSDERMAL | 1 0.01 84.82 30 MG, BID | 2 0.02 84.84 30 MG, DAILY | 4 0.04 84.88 30 MG, DAILY (1/D) | 4 0.04 84.92 30 MG, EACH EVENING | 1 0.01 84.93 30 MG, ORAL | 1 0.01 84.94 30 MG, PRN | 1 0.01 84.95 30 MG, QD | 3 0.03 84.98 30 MG, QMO | 1 0.01 84.99 30 MG, TID | 1 0.01 85.00 30 MG, UNK | 4 0.04 85.04 30 MG, UNKNOWN | 2 0.02 85.06 30 MG/DAY | 1 0.01 85.07 30 MG/EVERY 14 DAYS | 1 0.01 85.08 30 MINUTES AFTER ADMISSION | 1 0.01 85.09 30 UG QW IM | 21 0.21 85.30 30 UG; QW; IM | 13 0.13 85.43 30 UNITS IV | 1 0.01 85.44 30 UNK, UNK | 1 0.01 85.45 300 A?G, Q2W | 1 0.01 85.46 300 MG BID ORAL | 1 0.01 85.47 300 MG DAILY | 2 0.02 85.49 300 MG QD; PO | 2 0.02 85.51 300 MG QM IV | 1 0.01 85.52 300 MG, 2/D | 1 0.01 85.53 300 MG, 3X/DAY | 1 0.01 85.54 300 MG, BID | 2 0.02 85.56 300 MG, DAILY | 1 0.01 85.57 300 MG, ORAL; 75 MG, QD, ORAL | 1 0.01 85.58 300 MG, QD | 3 0.03 85.61 300 MG, TID | 2 0.02 85.63 300 MG, UNK | 6 0.06 85.69 300 MG/D | 2 0.02 85.71 300 MG/D, UNK | 1 0.01 85.72 300 MG/DAY | 4 0.04 85.76 300 MG/M2=500 MG BOLUS THEN 500 MG/M2.. | 1 0.01 85.77 300 MG; QM; IV | 2 0.02 85.79 300 MG;QM;IV | 1 0.01 85.80 3000 MG, AT ONCE | 1 0.01 85.81 3000 MG, DAILY (1/D) | 1 0.01 85.82 3000 MG, QD | 1 0.01 85.83 30000IU AS DIRECTED | 1 0.01 85.84 3000MG PER DAY | 1 0.01 85.85 300MG PER DAY | 2 0.02 85.87 30MG AT NIGHT | 1 0.01 85.88 30MG PER DAY | 2 0.02 85.90 3150MG UNKNOWN | 1 0.01 85.91 32 U, EACH EVENING | 1 0.01 85.92 320 MG, ONCE/SINGLE | 1 0.01 85.93 320 MG, QD | 1 0.01 85.94 320MG DAILY | 1 0.01 85.95 325 MG, DAILY (1/D) | 2 0.02 85.97 325 MG, QD | 1 0.01 85.98 325 MG, UNK | 1 0.01 85.99 325 MG/DAY | 1 0.01 86.00 325 MG; UNSPECIFIED FREQUENCY | 1 0.01 86.01 325MG PER DAY | 1 0.01 86.02 328 MG QD IV | 1 0.01 86.03 3360 UG QD BUCCAL | 1 0.01 86.04 34 INFUSIONS GIVEN | 1 0.01 86.05 35 MG/M2, DAYS 1, 8, 15 | 1 0.01 86.06 35 MG, 1/WEEK | 1 0.01 86.07 350 MG QD; PO | 1 0.01 86.08 350 MG/DAY | 1 0.01 86.09 3500 CGY | 1 0.01 86.10 35MG PER DAY | 1 0.01 86.11 35TH INFUSION | 1 0.01 86.12 36MG PER DAY | 1 0.01 86.13 37 MCG, DAILY, INTRATHECAL | 1 0.01 86.14 37.5 MG; UNSPECIFIED FREQUENCY | 1 0.01 86.15 37.5/25MG, QD | 1 0.01 86.16 37.5MG PER DAY | 2 0.02 86.18 375 MG, Q2W | 1 0.01 86.19 375 MG/M2, DAY 1 EVERY TWO WEEKS | 1 0.01 86.20 375MG/DAY | 1 0.01 86.21 38 IU, QD | 1 0.01 86.22 3800-4000 MG, SINGLE | 1 0.01 86.23 3G PER DAY | 1 0.01 86.24 3G THREE TIMES PER DAY | 2 0.02 86.26 3GX2/D | 1 0.01 86.27 3MGM2 CYCLIC | 1 0.01 86.28 3RD COURSE. | 1 0.01 86.29 3TAB PER DAY | 1 0.01 86.30 4 (PLUS) VIALS SOMETIME BEFORE 2002 | 1 0.01 86.31 4 MG, 2/D | 1 0.01 86.32 4 MG, 4/D | 1 0.01 86.33 4 MG, ONCE/SINGLE | 2 0.02 86.35 4 MG, Q2H PRN | 1 0.01 86.36 4 MG, QD | 1 0.01 86.37 4 MG, QMO | 2 0.02 86.39 4 MG, TIW | 1 0.01 86.40 4 MG, UNK | 8 0.08 86.48 4 MG/D | 1 0.01 86.49 4 MG/D, UNK | 2 0.02 86.51 4 MG/DAILY | 1 0.01 86.52 4 MIU, EVERY 2D | 1 0.01 86.53 4.5 MG/DAILY | 1 0.01 86.54 40 MG, QD, PO ALTERNATING | 1 0.01 86.55 40 MG (20 MG) | 1 0.01 86.56 40 MG (20 MG, 2 IN 1 D) | 1 0.01 86.57 40 MG / DAY | 1 0.01 86.58 40 MG 3 TIMES WEEKLY | 1 0.01 86.59 40 MG ONCE DAILY ON MONDAY, WEDNESDAY.. | 1 0.01 86.60 40 MG TWICE A DAY ORAL | 1 0.01 86.61 40 MG, BID, PO | 1 0.01 86.62 40 MG, DAILY | 2 0.02 86.64 40 MG, DAILY (1/D) | 4 0.04 86.68 40 MG, EACH MORNING | 1 0.01 86.69 40 MG, QD | 5 0.05 86.74 40 MG, QD, ORAL | 2 0.02 86.76 40 MG, UNK | 8 0.08 86.84 40 MG, UNKNOWN | 1 0.01 86.85 40 MG/D ON MONDAY, WEDNESDAY AND FRID.. | 1 0.01 86.86 40 MG; UNSPECIFIED FREQUENCY | 1 0.01 86.87 40 ML, 1 DOSE | 1 0.01 86.88 40 U, DAILY (1/D) | 1 0.01 86.89 40 U, EACH EVENING | 1 0.01 86.90 40.00 ML, ORAL | 1 0.01 86.91 400 MG | 1 0.01 86.92 400 MG PO DAILY | 1 0.01 86.93 400 MG (200 MG, 2 IN 1 D) | 8 0.08 87.01 400 MG (200 MG, 2 IN 1 D), ORAL | 1 0.01 87.02 400 MG QD; PO | 1 0.01 87.03 400 MG, 8 IN 1 D, ORAL | 1 0.01 87.04 400 MG, BID | 1 0.01 87.05 400 MG, DAILY | 1 0.01 87.06 400 MG, PRN | 1 0.01 87.07 400 MG, QD | 7 0.07 87.14 400 MG, TID | 1 0.01 87.15 400 MG, UNK | 1 0.01 87.16 400 MG/D | 1 0.01 87.17 400 MG/DAY | 3 0.03 87.20 400 MG; BID; PO | 1 0.01 87.21 400 MG; UNSPECIFIED FREQUENCY | 1 0.01 87.22 400 UNK, PRN | 1 0.01 87.23 4000 IU, QW3 | 1 0.01 87.24 4000 MG, QD | 2 0.02 87.26 40000 IU, QW | 1 0.01 87.27 40000 IU; QW; SC | 1 0.01 87.28 400MG ALTERNATE DAYS | 1 0.01 87.29 400MG PER DAY | 7 0.07 87.36 400MG QD PO | 1 0.01 87.37 400MG/100MG TWICE A DAY ORAL | 1 0.01 87.38 40MG ONCE DAILY ALTERNATING WITH 80MG.. | 2 0.02 87.40 40MG PER DAY | 9 0.09 87.49 40MG SINGLE DOSE | 1 0.01 87.50 40MG UNKNOWN | 1 0.01 87.51 42 MG IV | 1 0.01 87.52 420 MG, QD | 1 0.01 87.53 423.7 MCG, DAILY, INTRATHECAL | 1 0.01 87.54 44 A?G, 5X/WEEK | 1 0.01 87.55 44 MCG, 3 IN 1 WEEKS, SUBCUTANEOUS | 2 0.02 87.57 4480 UG QD BUCCAL | 1 0.01 87.58 45 MG, DAILY (1/D) | 1 0.01 87.59 45 MG, QMO | 1 0.01 87.60 45 MG/D | 1 0.01 87.61 45 MG/M2, UNK | 1 0.01 87.62 45 MG; ORAL | 1 0.01 87.63 450 MG, Q2W | 1 0.01 87.64 450MG PER DAY | 1 0.01 87.65 450MGD SEE DOSAGE TEXT | 1 0.01 87.66 45MG PER DAY | 2 0.02 87.68 48.25 | 1 0.01 87.69 48.8 MG, BOLUS, IV BOLUS; 110 MG,HR, .. | 1 0.01 87.70 4G PER DAY | 1 0.01 87.71 4MG 1 TABLET DAILY PO | 1 0.01 87.72 4MG EVERY 4WEEKS | 1 0.01 87.73 4MG PER DAY | 3 0.03 87.76 4MG QMOS | 1 0.01 87.77 4MG TWICE PER DAY | 2 0.02 87.79 4MGM2 CYCLIC | 3 0.03 87.82 4MU FOUR TIMES PER DAY | 1 0.01 87.83 4TAB PER DAY | 1 0.01 87.84 4TAB TWICE PER DAY | 1 0.01 87.85 5 COURSES | 2 0.02 87.87 5 IU;BID;IV, 0.25 MG/KG,XI; IV | 1 0.01 87.88 5 MG AT NIGHT PRN | 1 0.01 87.89 5 MG EVERY 1 CYC | 1 0.01 87.90 5 MG IN AM, 2.5 MG IN AFTERNOON, 2.5 .. | 1 0.01 87.91 5 MG QD ORAL | 1 0.01 87.92 5 MG, 2/D | 3 0.03 87.95 5 MG, BID | 1 0.01 87.96 5 MG, DAILY (1/D) | 2 0.02 87.98 5 MG, EACH EVENING | 1 0.01 87.99 5 MG, EACH MORNING | 1 0.01 88.00 5 MG, PRN | 1 0.01 88.01 5 MG, QD | 6 0.06 88.07 5 MG, QD MID-DAY | 1 0.01 88.08 5 MG, SINGLE AT BEDTIME | 1 0.01 88.09 5 MG, UNK | 3 0.03 88.12 5 MG, UNKNOWN | 1 0.01 88.13 5 MG/D, UNK | 1 0.01 88.14 5 MG/DAILY | 2 0.02 88.16 5 MG/KG, 1/WEEK | 1 0.01 88.17 5 TABLETS | 1 0.01 88.18 5 U, EACH EVENING | 1 0.01 88.19 5 UG, 2/D | 12 0.12 88.31 5 UG, 2/D, SUBCUTANEOUS; 10 UG, 2/D, .. | 1 0.01 88.32 5 UG, SUBCUTANEOUS | 1 0.01 88.33 5 UG, UNKNOWN | 2 0.02 88.35 5 UG/MIN | 1 0.01 88.36 5-10 MG AT BEDTIME, PRN | 1 0.01 88.37 5/20 MG, QD | 1 0.01 88.38 50 A?G, QD | 1 0.01 88.39 50 MG / DAY | 1 0.01 88.40 50 MG DAILY | 1 0.01 88.41 50 MG ONCE DAILY | 1 0.01 88.42 50 MG WEEKLY | 1 0.01 88.43 50 MG, 1 IN 1 D, ORAL, 100 MG, 1 IN 1.. | 1 0.01 88.44 50 MG, 2/D | 1 0.01 88.45 50 MG, BID | 2 0.02 88.47 50 MG, DAILY (1/D) | 2 0.02 88.49 50 MG, PRN | 1 0.01 88.50 50 MG, QD | 8 0.08 88.58 50 MG, TID | 1 0.01 88.59 50 MG, UNK | 3 0.03 88.62 50 MG/D | 2 0.02 88.64 50 MG/DAILY/PO | 1 0.01 88.65 50 MG/DAY | 6 0.06 88.71 50 MG/M2, UNK | 1 0.01 88.72 50 U, EACH EVENING | 1 0.01 88.73 50 U, EACH MORNING | 1 0.01 88.74 50 U, UNK | 1 0.01 88.75 50 UNK, QD | 1 0.01 88.76 50-200 MG/H | 1 0.01 88.77 50/12.5 MG | 1 0.01 88.78 50/500 | 1 0.01 88.79 500 MG | 1 0.01 88.80 500 MG EVERY OTHER DAY | 1 0.01 88.81 500 MG QD; PO | 2 0.02 88.83 500 MG, 2/D | 2 0.02 88.85 500 MG, BID | 2 0.02 88.87 500 MG, DAILY (1/D) | 1 0.01 88.88 500 MG, QD | 3 0.03 88.91 500 MG, TID | 2 0.02 88.93 500 MG, UNK | 3 0.03 88.96 500 MG/D, UNK | 1 0.01 88.97 500 MG/M2, UNK | 1 0.01 88.98 500 UNK, QD | 1 0.01 88.99 5000 IU, QD | 1 0.01 89.00 500MG PER DAY | 5 0.05 89.05 500MG THREE TIMES PER DAY | 2 0.02 89.07 500MG TWICE PER DAY | 2 0.02 89.09 500MG UNKNOWN | 1 0.01 89.10 50MG | 1 0.01 89.11 50MG BID PO | 1 0.01 89.12 50MG EVERY MORNING PO 25MG EVERY EV.. | 1 0.01 89.13 50MG QWEEK SQ | 1 0.01 89.14 50MG PER DAY | 4 0.04 89.18 50MG TWICE PER DAY | 1 0.01 89.19 50MG UNKNOWN | 1 0.01 89.20 50MG02-AUG-2006 TO 31-AUG-2006,75MG 0.. | 1 0.01 89.21 5100 IU | 1 0.01 89.22 54 MG, UNK | 2 0.02 89.24 54 U, EACH EVENING | 1 0.01 89.25 540 MG (400 MG/M2) IV BOLUS FOLLOWED .. | 1 0.01 89.26 550 MG,/D | 1 0.01 89.27 560 MG, QD | 1 0.01 89.28 5MG PER DAY | 10 0.10 89.38 6 COURSES | 3 0.03 89.41 6 G/DAY | 1 0.01 89.42 6 IU, UNK | 1 0.01 89.43 6 MG, BID | 1 0.01 89.44 6 MIU, EVERY 2D | 1 0.01 89.45 6 ML, TID | 2 0.02 89.47 6.2 MG/KG; Q24H; IV | 1 0.01 89.48 6.25 MG, 2/D | 1 0.01 89.49 6.25 MG, QD | 1 0.01 89.50 60 MCG SQ BID | 1 0.01 89.51 60 MG, 2/D | 1 0.01 89.52 60 MG, DAILY | 3 0.03 89.55 60 MG, DAILY (1/D) | 7 0.07 89.62 60 MG, EACH EVENING | 1 0.01 89.63 60 MG, QAM | 1 0.01 89.64 60 MG, QD | 2 0.02 89.66 60 MG, UNK | 5 0.05 89.71 60 MG/H | 1 0.01 89.72 60 U, EACH EVENING | 1 0.01 89.73 60.83 U/KG Q3WKS IV | 1 0.01 89.74 600 MG, | 1 0.01 89.75 600 MG, AT ONCE | 1 0.01 89.76 600 MG, BID | 4 0.04 89.80 600 MG, DAILY (1/D) | 1 0.01 89.81 600 MG, QD | 3 0.03 89.84 600 MG, UNK | 2 0.02 89.86 600 MG/DAY | 2 0.02 89.88 600 MG; UNSPECIFIED FREQUENCY | 1 0.01 89.89 600 MGQD; PO | 1 0.01 89.90 600MG FOUR TIMES PER DAY | 1 0.01 89.91 600MG PER DAY | 1 0.01 89.92 600MG THREE TIMES PER DAY | 1 0.01 89.93 60MG PER DAY | 1 0.01 89.94 625MG TWICE PER DAY | 1 0.01 89.95 650 MG, AS NEEDED | 1 0.01 89.96 650 MG, PRN | 1 0.01 89.97 650 MG/DAY | 1 0.01 89.98 650 UNK, PRN | 1 0.01 89.99 6MG PER DAY | 1 0.01 90.00 6MG, UNK | 1 0.01 90.01 7 GTT, TID | 1 0.01 90.02 7 MG, PRN | 1 0.01 90.03 7.2 MG X 2 | 1 0.01 90.04 7.5 MG, DAILY (1/D) | 1 0.01 90.05 7.5 MG, QD | 2 0.02 90.07 7.5 MG, UNK | 1 0.01 90.08 7.5 MG, UNKNOWN | 1 0.01 90.09 7.5/200 MG PRN | 1 0.01 90.10 7.5MG PER DAY | 2 0.02 90.12 70 MG, DAILY | 2 0.02 90.14 70 MG, QW | 2 0.02 90.16 70/2800 | 1 0.01 90.17 700 KIU, DAILY | 1 0.01 90.18 700MG UNKNOWN | 1 0.01 90.19 70MG PER DAY | 1 0.01 90.20 720 MG DAILY | 1 0.01 90.21 720 MG, BID | 2 0.02 90.23 724MG | 1 0.01 90.24 75 A?G, QD | 1 0.01 90.25 75 MCG Q3DAYS | 1 0.01 90.26 75 MG / DAY | 1 0.01 90.27 75 MG EVERY | 1 0.01 90.28 75 MG QD; PO | 1 0.01 90.29 75 MG, 3/D | 1 0.01 90.30 75 MG, FREQUENCY UNKNOWN | 1 0.01 90.31 75 MG, QD | 2 0.02 90.33 75 MG, TID | 1 0.01 90.34 75 MG, UNK | 1 0.01 90.35 75 MG/D | 1 0.01 90.36 75 MG/DAY | 2 0.02 90.38 75 UG, DAILY (1/D) | 1 0.01 90.39 75 UG, UNK | 2 0.02 90.41 750 MG, 1/WEEK | 1 0.01 90.42 750 MG, PRN | 1 0.01 90.43 750 MG, Q3W | 1 0.01 90.44 7500MCG WEEKLY | 1 0.01 90.45 750MG PER DAY | 1 0.01 90.46 75MG PER DAY | 1 0.01 90.47 8 - 10 DF /DAY | 1 0.01 90.48 8 GTT, Q4H | 1 0.01 90.49 8 IU, QD | 1 0.01 90.50 8 MG, QD | 2 0.02 90.52 8 MG, UNK | 1 0.01 90.53 8 MIU, EVERY 2D | 14 0.14 90.67 8 MIU, OTHER | 1 0.01 90.68 8 MIU, UNK | 1 0.01 90.69 80 / 4.5 UG, 2 INHALATIONS TWICE DAILY | 1 0.01 90.70 80 MCG; 50 MCG | 1 0.01 90.71 80 MG, BID | 4 0.04 90.75 80 MG, DAILY | 3 0.03 90.78 80 MG, ONCE/SINGLE | 1 0.01 90.79 80 MG, QD | 4 0.04 90.83 80 MG, UID/QD, IV DRIP; 300 MG, IV DRIP | 1 0.01 90.84 80 MG, UNK | 2 0.02 90.86 80 MG/D | 1 0.01 90.87 80 MG/D, UNK | 1 0.01 90.88 80 MG/DAILY | 1 0.01 90.89 80 MG/DAY | 1 0.01 90.90 80 ML, SINGLE | 1 0.01 90.91 80.5MG PER DAY | 2 0.02 90.93 80/12.5 | 1 0.01 90.94 80/12.5 MG | 1 0.01 90.95 800 MG (200 MG, 4 IN 1 D) | 1 0.01 90.96 800 MG (400 MG, 2 IN 1 D); | 1 0.01 90.97 800 MG DAILY | 1 0.01 90.98 800 MG, UNK | 2 0.02 91.00 800 MG/D | 1 0.01 91.01 800 MG; TID; PO | 1 0.01 91.02 800 UNITS Q2WKS IV | 1 0.01 91.03 800/200 MILLIGRAMS | 2 0.02 91.05 800MG | 2 0.02 91.07 800MG PER DAY | 1 0.01 91.08 80MG PER DAY | 2 0.02 91.10 80MG, UNK | 1 0.01 91.11 81 MG, DAILY (1/D) | 1 0.01 91.12 81 MG, QD | 3 0.03 91.15 81 MG, QD, ORAL | 1 0.01 91.16 81 MG, UNK | 1 0.01 91.17 81 MG/D, UNK | 1 0.01 91.18 81MG PER DAY | 1 0.01 91.19 81MG UNKNOWN | 1 0.01 91.20 877.5 MG IV | 1 0.01 91.21 88 MCG, QD | 1 0.01 91.22 885 MG, Q3W | 1 0.01 91.23 8MG PER DAY | 2 0.02 91.25 8MG UNKNOWN | 1 0.01 91.26 9 MG, BID | 1 0.01 91.27 9 MIU, EVERY 6-8 MONTHS | 1 0.01 91.28 90 MG IN THE MORNING + 30 MG AT NIGHT | 1 0.01 91.29 90 MG, DAILY (1/D) | 1 0.01 91.30 90 MG, QD | 1 0.01 91.31 900 IU, UNK | 1 0.01 91.32 900 MG, QD | 2 0.02 91.34 900 MG/DAY | 1 0.01 91.35 900MG EACH MORNING AND 1200 MG AT NIGHT | 1 0.01 91.36 900MG PER DAY | 1 0.01 91.37 90MG PER DAY | 2 0.02 91.39 9MG/500MG/4 MONTHLY | 1 0.01 91.40 ;PRN;INHALATION | 1 0.01 91.41 ACCIDENTALLY TOOK 2 ARIMIDEX 1 MG TAB.. | 1 0.01 91.42 ACCUTANE 40 MG/DAY ON MONDAY, WEDNESD.. | 1 0.01 91.43 ACCUTANE INCREASED TO 80MG EVERY THIR.. | 1 0.01 91.44 AMOUNT AND LAST USE UNKNOWN | 2 0.02 91.46 AMOUNT OF ALCOHOL CONSUMED UNKNOWN | 1 0.01 91.47 APPLIED TO FOREARMS. | 1 0.01 91.48 APPLIED TO HANDS. | 1 0.01 91.49 APPLIED TO LIPS. | 1 0.01 91.50 APPLY 1 HR BEFORE TOPICAL | 1 0.01 91.51 BOLUS ON DEMAND | 1 0.01 91.52 COMMENCED THREE DAYS PRIOR TO ADMISSION | 2 0.02 91.54 CYCLE 1:02 TO 04-JUN-2006,CYCLE 2:30-.. | 2 0.02 91.56 CYCLE 1; CYCLE 2; CYCLE 3; CYCLE 4; C.. | 1 0.01 91.57 D1-D2 | 1 0.01 91.58 DAILY DOSE : 688MG | 1 0.01 91.59 DAILY DOSE DEPENDS ON BLOOD SUGAR LEVEL | 1 0.01 91.60 DAILY DOSE: 279 MG DOSE ON 08 AUG 2007 | 1 0.01 91.61 DAILY DOSE: 74 MG DOSE ON 08 AUG 2007 | 1 0.01 91.62 DAILY DOSE: UNKNOWN | 8 0.08 91.70 DAILY DOSE: 2790 MG, BOLUS OMITTED ON.. | 1 0.01 91.71 DAILY DOSE: 744 MG DOSE ON 08 AUG 2007 | 1 0.01 91.72 DAILY DOSE:.25MG | 1 0.01 91.73 DAILY DOSE:.6MG | 1 0.01 91.74 DAILY DOSE:.8MG-FREQ:ONCE | 2 0.02 91.76 DAILY DOSE:100MG-FREQ:WEEKLY | 1 0.01 91.77 DAILY DOSE:10MG | 4 0.04 91.81 DAILY DOSE:12.5MG | 1 0.01 91.82 DAILY DOSE:1200MG | 1 0.01 91.83 DAILY DOSE:140MG | 1 0.01 91.84 DAILY DOSE:150MCG | 1 0.01 91.85 DAILY DOSE:150MG | 2 0.02 91.87 DAILY DOSE:160MG | 1 0.01 91.88 DAILY DOSE:1MG | 1 0.01 91.89 DAILY DOSE:2.25MG-TEXT:SINGLE ADMINIS.. | 1 0.01 91.90 DAILY DOSE:2.5MG | 1 0.01 91.91 DAILY DOSE:200MG | 3 0.03 91.94 DAILY DOSE:200MG-FREQ:ONCE | 1 0.01 91.95 DAILY DOSE:20MG | 1 0.01 91.96 DAILY DOSE:225MG-TEXT:75MG AND 150MG .. | 1 0.01 91.97 DAILY DOSE:25MG | 1 0.01 91.98 DAILY DOSE:25MG-FREQ:DAILY | 1 0.01 91.99 DAILY DOSE:2MG | 1 0.01 92.00 DAILY DOSE:2MG-FREQ:CYCLIC : CYCLIC | 1 0.01 92.01 DAILY DOSE:3.2MG | 1 0.01 92.02 DAILY DOSE:400MG | 1 0.01 92.03 DAILY DOSE:4MG | 2 0.02 92.05 DAILY DOSE:500MG | 2 0.02 92.07 DAILY DOSE:50MG | 5 0.05 92.12 DAILY DOSE:50MG-FREQ:28 DAYS ON /14 D.. | 1 0.01 92.13 DAILY DOSE:50MG-FREQ:DAILY | 1 0.01 92.14 DAILY DOSE:600MG | 1 0.01 92.15 DAILY DOSE:60MG | 1 0.01 92.16 DAILY DOSE:75MCG-FREQ:DAILY | 1 0.01 92.17 DAILY DOSE:8MG/KG-FREQ:EVERY DAY | 1 0.01 92.18 DAILY FOR ONE MONTH [EST. JUL1997], | 1 0.01 92.19 DEPO-LUPRON INJECTIONS1X MO. -EVERY 4.. | 1 0.01 92.20 DISCONTINUED 3 DAYS PRIOR TO ADMISSION. | 1 0.01 92.21 DISCONTINUED ON FIFTH HOSPITAL DAY | 1 0.01 92.22 DIVIDED INTO TWO DAILY DOSES, GIVEN F.. | 1 0.01 92.23 DOSAGE FORM REPORTED AS INFUSION. | 1 0.01 92.24 DOSAGE FORM REPORTED AS INFUSION. GI.. | 1 0.01 92.25 DOSAGE FORM REPORTED AS: PILL | 1 0.01 92.26 DOSAGE FORM: INFUSION. ADMINISTERED O.. | 1 0.01 92.27 DOSAGE RECEIVED IN MORNING | 1 0.01 92.28 DOSAGE RECEIVED: 2 EVERY 6 HOURS | 1 0.01 92.29 DOSAGE REGIMEN REPORTED AS: 200MG. | 1 0.01 92.30 DOSAGE REGIMEN: 0.5 DOSE DAILY. | 1 0.01 92.31 DOSAGE REGIMEN: 200 MG 5 D. | 1 0.01 92.32 DOSAGE REPORTED AS 200 MG 5X/ | 1 0.01 92.33 DOSAGE UNKNOWN | 1 0.01 92.34 DOSAGE: 16MG,12.5MG | 1 0.01 92.35 DOSAGE: 800+400MG/DAY. | 1 0.01 92.36 DOSE AND FREQUENCY NOT SPECIFIED | 3 0.03 92.39 DOSE AND FREQUENCY UNKNOWN | 1 0.01 92.40 DOSE CHANGED | 1 0.01 92.41 DOSE INCREASED. | 1 0.01 92.42 DOSE IS INCREASED TO ACCUTANE 40 MG O.. | 1 0.01 92.43 DOSE QUANTITY: 1 | 1 0.01 92.44 DOSE REPORTED AS 300 MG NOCTE. | 1 0.01 92.45 DOSE REPORTED AS 9 MIU | 1 0.01 92.46 DOSE UNIT:UNKNOWN | 24 0.24 92.70 DOSE UNKNOWN | 1 0.01 92.71 DOSE WAS REDUCED TO 400 MG/M2 FOR 3RD.. | 1 0.01 92.72 DOSE WAS REDUCED TO 60 MG/M2 FOR 3RD .. | 1 0.01 92.73 DOSE: 1 TABLET | 8 0.08 92.81 DOSE: 1 TABLET 50/12.5 MG | 1 0.01 92.82 DOSE: 10 UNITS | 1 0.01 92.83 DOSE: 150 MG/DAY FOR 2 WEEKS FOLLOWIN.. | 1 0.01 92.84 DOSE: 7-8 UNITS | 1 0.01 92.85 DOSE: NOT REPORTED | 7 0.07 92.92 DOSE: TWO | 1 0.01 92.93 DOSE: UNK | 30 0.30 93.23 DOSE: {40 | 1 0.01 93.24 DOSING AMOUNT AND FREQUENCY REPORTED .. | 1 0.01 93.25 DOSING REGIMEN 40 MG ON ODD DAYS AND .. | 1 0.01 93.26 DOSING REGIMEN REPORTED AS AFTER SHOW.. | 1 0.01 93.27 DOSING REGIMEN REPORTED AS QD TO UNDE.. | 1 0.01 93.28 DOSING REGIMEN REPORTED AS QHS. | 1 0.01 93.29 DOSING REGIMEN REPORTED AS QOD. | 1 0.01 93.30 DOUBLE BLIND | 4 0.04 93.34 DRUG NAME REPORTED AS AMALODOPINE. | 1 0.01 93.35 DRUG NAME REPORTED AS AZYTHROMICIN. | 1 0.01 93.36 DRUG NAME REPORTED AS BABY ASPIRIN | 1 0.01 93.37 DRUG NAME REPORTED AS BENZOFLUMETHIAZ.. | 1 0.01 93.38 DRUG NAME REPORTED AS UNSPECIFIED PSY.. | 1 0.01 93.39 DRUG REPORTED AS CODINE PHOSPHATE. | 1 0.01 93.40 DRUG REPORTED AS OXYPRENALOL. | 1 0.01 93.41 DRUG REPORTED AS PREINDOPRIL. | 1 0.01 93.42 DRUG: SODIUM VALPORATE. | 1 0.01 93.43 EIGHT DAYS PRIOR TO ADMISSION | 2 0.02 93.45 EVERY 3 DAYS | 1 0.01 93.46 EVERY 60 DAYS | 1 0.01 93.47 EVERY 90 DAYS | 1 0.01 93.48 EVERY OTHER DAY FOR 1-2 WEEKS AS NEED.. | 1 0.01 93.49 FIFTH HOSPITAL DAY | 1 0.01 93.50 FIRST INFUSION | 3 0.03 93.53 FOR 15 DAYS | 1 0.01 93.54 FOR 18 MONTHS | 1 0.01 93.55 FOR FIVE DAYS | 1 0.01 93.56 FORM REPORTED AS INJECTABLE SOLUTION | 1 0.01 93.57 FORM: CONC. FOR SOLUTION | 1 0.01 93.58 FORM: FILM COATED TABLETS. | 1 0.01 93.59 FORM: INFUSION, PERMANENTLY DISCONTIN.. | 1 0.01 93.60 FORM: INJECTABLE SOLUTION. | 1 0.01 93.61 FORM: INJECTION, PERMANENTLY DISCONTI.. | 1 0.01 93.62 FORM: PRE-FILLED SYRINGE, INDICATION:.. | 1 0.01 93.63 FORM: PREFILLED SYRINGE. | 1 0.01 93.64 FORM: REPORTED AS FILM COATED TABLET. | 1 0.01 93.65 FREQ:1 DF | 1 0.01 93.66 FREQ:AS NEEDED | 1 0.01 93.67 FREQ:MOST RECENT INJECTION | 1 0.01 93.68 FREQ:QD | 3 0.03 93.71 FREQ:UNKNOWN | 4 0.04 93.75 FREQUENCY REPORTED AS 50 MG/DAY. | 1 0.01 93.76 FREQUENCY REPORTED AS 137 MCG/DAY. | 1 0.01 93.77 FREQUENCY REPORTED AS 20 MG/DAY. | 1 0.01 93.78 FREQUENCY REPORTED AS 400 MCG/DAY. | 1 0.01 93.79 FREQUENCY REPORTED AS QD. | 1 0.01 93.80 FREQUENCY: EVERY 6 TO 8 HOURS | 1 0.01 93.81 FREQUENCY: QD; INTERVAL; DAILY) | 1 0.01 93.82 FRQUENCY REPORTED AS 40 MG/DAY. | 1 0.01 93.83 GIVEN FOR 1 MONTH | 1 0.01 93.84 GIVEN FROM DAYS ONE TO FOURTEEN OF EA.. | 1 0.01 93.85 GIVEN ON 24-AUG-2007 | 1 0.01 93.86 GIVEN ON DAY ONE EVERY THREE WEEKS. | 1 0.01 93.87 GIVEN ON DAY ONE TO FOURTEEN EVERY TH.. | 2 0.02 93.89 HAD 165MG(100MG/M2)ON 20-SEP-07.HELD .. | 1 0.01 93.90 IM | 9 0.09 93.99 IN JUL-92: PATIENT RECEIVED KENALOG I.. | 1 0.01 94.00 INCREASED TO 25 MG/WEEK | 1 0.01 94.01 INDICATION: HEPATITIS C (GENOTYPE 4) | 1 0.01 94.02 INFUSED 4, 7 AND 9 DAYS AFTER BLOOD T.. | 1 0.01 94.03 INFUSION ON D1+2 | 1 0.01 94.04 INFUSIONS AT WEEKS 0, 2, 6, AND 14 | 1 0.01 94.05 INHALATION BY NEBULIZER | 1 0.01 94.06 INITIAL DOSE 4 MG, INCREASED TO 8 MG .. | 1 0.01 94.07 INJ | 1 0.01 94.08 INJECTABLE | 1 0.01 94.09 INTERRUPTED 12-MAY-2005. | 1 0.01 94.10 INTRAVENOUS | 1 0.01 94.11 KALETRA TABLETS | 1 0.01 94.12 LAST INFUSION | 1 0.01 94.13 LEVEL 1 | 3 0.03 94.16 LEVEL 2 | 2 0.02 94.18 LOADING DOSE GIVEN ON DAY ONE AS PER .. | 1 0.01 94.19 LUNCH TIME | 1 0.01 94.20 LYOPHILIZED 50 MG ONCE WEEKLY | 1 0.01 94.21 LYOPHILIZED: 50 MG 1 TIME PER WEEK | 1 0.01 94.22 MAXIMUM 10 TABLETS | 1 0.01 94.23 MAXIMUM 10 TABLETS ORAL | 2 0.02 94.25 MAXIMUM 20 TABLETS | 2 0.02 94.27 MAXIMUM 20 TABLETS ORAL | 4 0.04 94.31 MAXIMUM 50 TABLETS | 2 0.02 94.33 MAXIMUM 50 TABLETS ORAL | 4 0.04 94.37 MAXIMUM DOSE IS 14 MG FOR A MAXIMUM O.. | 1 0.01 94.38 MAXIMUM OF 1 TABLET (1 DOSAGE FORMS) | 1 0.01 94.39 MAXIMUM OF 1 TABLET (1 DOSAGE FORMS) .. | 2 0.02 94.41 MAXIMUM OF 100 TABLETS | 1 0.01 94.42 MAXIMUM OF 100 TABLETS ORAL | 2 0.02 94.44 MAXIMUM OF 49 TABLETS TAKEN | 1 0.01 94.45 MAXIMUM OF 49 TABLETS TAKEN ORAL | 2 0.02 94.47 MCG, DAILY, INTRATHECAL | 5 0.05 94.52 MERIEUX | 1 0.01 94.53 MG ORAL | 1 0.01 94.54 MORNING + EVENING | 1 0.01 94.55 MOST RECENT INFUSION ON 09-SEP-04. | 2 0.02 94.57 NEBULIZER. | 1 0.01 94.58 NO TREATMENT | 2 0.02 94.60 NOT PROVIDED | 2 0.02 94.62 ON 13-SEP-07 DOSE=660MG,400MG/M2.2312.. | 1 0.01 94.63 ON ADMISSION | 5 0.05 94.68 ON ADMISSION TO THIRD HOSPITAL DAY | 1 0.01 94.69 ON HOLD | 6 0.06 94.75 ONCE WEEKLY | 1 0.01 94.76 ONE DOSE | 2 0.02 94.78 ONE TABLET | 1 0.01 94.79 ONE TABLET ONE TIME PO | 1 0.01 94.80 ONE TWICE DAILY | 1 0.01 94.81 ORAL | 12 0.12 94.93 PATIENT IN WEEK 16 OF THERAPY. | 2 0.02 94.95 PATIENT TOOK TWO DOSES (AMOUNT AND FO.. | 1 0.01 94.96 PATIENT UNSURE ABOUT DOSING REGIMEN. | 1 0.01 94.97 PER ORAL | 2 0.02 94.99 PFS: 50 MG 2 TIMES PER WEEK | 1 0.01 95.00 PO | 11 0.11 95.11 PREFILLED SYRINGE 50 MG ONCE WEEKLY | 2 0.02 95.13 QD; ON HOLD | 1 0.01 95.14 QD; PO | 1 0.01 95.15 REDUCED TO 10MG/DAY | 1 0.01 95.16 REPORTED AS 'DAYTIME AND NIGHTTIME CO.. | 1 0.01 95.17 REPORTED AS 325 MG/DAY | 1 0.01 95.18 REPORTED AS CALCIUM WITH D 1200 MG/DAY | 1 0.01 95.19 REPORTED AS DAILY MULTIVITAMIN | 1 0.01 95.20 REPORTED AS OMAPROZOLE 20 MG/DAY. | 1 0.01 95.21 REPORTED AS ^BLOOD PRESSURE MEDICATION^ | 1 0.01 95.22 REPORTED IN THE NARRATIVE | 1 0.01 95.23 REPORTED INDICATION 'PAINS TO KNEES A.. | 1 0.01 95.24 REPORTED INDICATION INCLUDED BOTH DRY.. | 1 0.01 95.25 REPORTED TO HAVE TAKEN 4 CYCLES. LAST.. | 2 0.02 95.27 REQUEST IN INCREASE DOSAGE FROM 5 TO .. | 1 0.01 95.28 RESTARTED ON 28 JUL 2004 FOR OTITIS E.. | 1 0.01 95.29 ROUTE REPORTED AS OS. | 1 0.01 95.30 SC | 2 0.02 95.32 SECOND INDICATION REPORTED AS RELAPSI.. | 1 0.01 95.33 SEE IMAGE | 2 0.02 95.35 SIX CYCLES RECEIVED | 2 0.02 95.37 SLIDING SCALE | 1 0.01 95.38 SLOWLY INCREASING DOSAGE AND IN MID A.. | 1 0.01 95.39 SOURCE: HOSPITAL PHARMACY | 1 0.01 95.40 SOURCE: HOSPITAL PHARMACY. ADMINISTR.. | 1 0.01 95.41 STARTED AT 20 MG TWICE DAILY AND LATE.. | 1 0.01 95.42 STARTED BEFORE FEBRUARY 2005. | 3 0.03 95.45 STARTED BEFORE FEBRUARY 2007. | 1 0.01 95.46 STARTED LONG BEFORE TRIAL MEDICATION. | 5 0.05 95.51 STARTED LONG BEFORE TRIAL MEDICATION... | 1 0.01 95.52 STARTED ON 26-JUL @ 70MG BID.STOPPED .. | 1 0.01 95.53 STARTED PRE-TRIAL | 9 0.09 95.62 STARTED THREE DAYS PRIOR TO ADMISSION | 1 0.01 95.63 STAVUDINE 60 MG OR 80 MG/LAMIVUDINE 3.. | 1 0.01 95.64 STAVUDINE 60 MG OR 80 MG/LAMIVUDINE 3.. | 1 0.01 95.65 STOPPED AND RESTARTED IN 04 APR 2002 .. | 1 0.01 95.66 STOPPED AND RESTARTED IN 04 APR 2002. | 1 0.01 95.67 STOPPED AND RETAKEN ON 3 MAR 2005. | 1 0.01 95.68 STRENGTH AND FORMULATION REPORTED AS .. | 1 0.01 95.69 STRENGTH REPORTED AS 0.03 MG/3 MG TAB.. | 1 0.01 95.70 STRENGTH REPORTED AS CHLORPHENAMINE (.. | 1 0.01 95.71 STRENGTH. 40 MG. | 1 0.01 95.72 STRENGTH: 50MG LEVODOPA/ 12,5MG BENSE.. | 1 0.01 95.73 SUBCUTANEOUS | 1 0.01 95.74 SWITCHED BACK TO NOLVADEX (AFTER TAKI.. | 1 0.01 95.75 SWITCHED TO ARIMIDEX | 1 0.01 95.76 TABLET TAKEN BEFORE BED | 1 0.01 95.77 TAKEN AS NEEDED | 1 0.01 95.78 TAKEN IN THE MORNING | 1 0.01 95.79 TAKEN IRREGULARLY | 1 0.01 95.80 TAKEN ONCE EVERY THREE TO FIVE DAYS A.. | 1 0.01 95.81 TAKEN PRIOR TO SURGERY ON 22 AUG-01. | 1 0.01 95.82 TBSO QD | 1 0.01 95.83 TEXT:1 CAPSULE-FREQ:QD | 1 0.01 95.84 TEXT:1 CC PER MONTH | 1 0.01 95.85 TEXT:10 MEGA | 1 0.01 95.86 TEXT:10/650 1-2 Q 4-6 | 1 0.01 95.87 TEXT:100 | 1 0.01 95.88 TEXT:100 MG | 1 0.01 95.89 TEXT:1000 | 1 0.01 95.90 TEXT:1CC PER MONTH | 1 0.01 95.91 TEXT:1TABLET-FREQ:1X/DAY: EVERYDAY | 1 0.01 95.92 TEXT:200 | 1 0.01 95.93 TEXT:3X30 DROPS | 1 0.01 95.94 TEXT:4 MG | 1 0.01 95.95 TEXT:40 | 1 0.01 95.96 TEXT:40 MG | 2 0.02 95.98 TEXT:40 MILLIGRAMS | 1 0.01 95.99 TEXT:4200 UI | 1 0.01 96.00 TEXT:5/500 MG-FREQ:PRN Q6HRS | 1 0.01 96.01 TEXT:500 MG | 1 0.01 96.02 TEXT:75 MG | 2 0.02 96.04 TEXT:8 MG X 3 DOSES | 1 0.01 96.05 TEXT:90 MG | 1 0.01 96.06 TEXT:EVERY DAY | 1 0.01 96.07 TEXT:EVERYDAY | 2 0.02 96.09 TEXT:MAX. 12 MG-FREQ:DAILY, AS NECESS.. | 1 0.01 96.10 TEXT:ONE DOSE FORM | 1 0.01 96.11 TEXT:TABLET 100MG PRN | 1 0.01 96.12 TEXT:UNKNOWN | 6 0.06 96.18 TEXT:UNKNOWN-FREQ:UNKNOWN | 2 0.02 96.20 THIRD HOSPITAL DAY: ROUTE : NASOGASTR.. | 1 0.01 96.21 TITRATED FROM 15G/DAY TO 20MG/DAY | 1 0.01 96.22 TITRATED TO 400MG | 1 0.01 96.23 TOTAL DAILY DOSE: 0.25 MG UNIT DOSE:.. | 1 0.01 96.24 TOTAL DAILY DOSE: 1. MG UNIT DOSE: 0.. | 1 0.01 96.25 TOTAL DAILY DOSE: 1.5 G UNIT DOSE: 7.. | 1 0.01 96.26 TOTAL DAILY DOSE: 1000 MG | 1 0.01 96.27 TOTAL DAILY DOSE: 15 MG | 1 0.01 96.28 TOTAL DAILY DOSE: 150 MG | 1 0.01 96.29 TOTAL DAILY DOSE: 16000 U UNIT DOSE:.. | 1 0.01 96.30 TOTAL DAILY DOSE: 17.5 MG | 1 0.01 96.31 TOTAL DAILY DOSE: 2 G UNIT DOSE: 2 G | 1 0.01 96.32 TOTAL DAILY DOSE: 20 MG | 1 0.01 96.33 TOTAL DAILY DOSE: 200 MG | 1 0.01 96.34 TOTAL DAILY DOSE: 200 MG UNIT DOSE: .. | 1 0.01 96.35 TOTAL DAILY DOSE: 220 MG UNIT DOSE: .. | 1 0.01 96.36 TOTAL DAILY DOSE: 30 MG | 2 0.02 96.38 TOTAL DAILY DOSE: 325 MG UNIT DOSE: .. | 2 0.02 96.40 TOTAL DAILY DOSE: 4 MIU UNIT DOSE: 2.. | 1 0.01 96.41 TOTAL DAILY DOSE: 40 MG | 1 0.01 96.42 TOTAL DAILY DOSE: 400 MG | 1 0.01 96.43 TOTAL DAILY DOSE: 400 MG UNIT DOSE: .. | 1 0.01 96.44 TOTAL DAILY DOSE: 400 MG UNIT DOSE: .. | 4 0.04 96.48 TOTAL DAILY DOSE: 5.4 G | 1 0.01 96.49 TOTAL DAILY DOSE: 50 MG | 1 0.01 96.50 TOTAL DAILY DOSE: 50 MG UNIT DOSE: 2.. | 1 0.01 96.51 TOTAL DAILY DOSE: 500 MG UNIT DOSE: .. | 1 0.01 96.52 TOTAL DAILY DOSE: 55 MG | 1 0.01 96.53 TOTAL DAILY DOSE: 60 MG | 2 0.02 96.55 TOTAL DAILY DOSE: 600 MG UNIT DOSE: .. | 1 0.01 96.56 TOTAL DAILY DOSE: 75 MG UNIT DOSE: 7.. | 1 0.01 96.57 TOTAL DAILY DOSE: 800 MG | 1 0.01 96.58 TOTAL DAILY DOSE: 800 MG UNIT DOSE: .. | 7 0.07 96.65 TOTAL DAILY DOSE: 81 MG UNIT DOSE: 8.. | 3 0.03 96.68 TOTAL DOSE OF 800 MG | 1 0.01 96.69 TOTAL OF 29 INFUSIONS | 1 0.01 96.70 TRADE NAME GIVEN AS: SITZ BATHS. | 1 0.01 96.71 TRADE NAME: CPAP. | 1 0.01 96.72 TRADE NAME: IL TAC. | 1 0.01 96.73 TWICE A DAY | 1 0.01 96.74 TWICE DAILY | 1 0.01 96.75 TWO DOSES ADMINISTERED | 1 0.01 96.76 UNIT DOSE: 325 MG | 1 0.01 96.77 UNK | 30 0.30 97.07 UNK BUCCAL | 1 0.01 97.08 UNK D/F, DAILY (1/D) | 1 0.01 97.09 UNK MG, DAYS 2-14 | 1 0.01 97.10 UNK MG, UNK | 6 0.06 97.16 UNK UNK, OTHER | 2 0.02 97.18 UNK, 1/MONTH | 3 0.03 97.21 UNK, 1/WEEK | 2 0.02 97.23 UNK, 1X/DAY | 1 0.01 97.24 UNK, 2/D | 1 0.01 97.25 UNK, 2/MONTH | 1 0.01 97.26 UNK, 2X/DAY | 1 0.01 97.27 UNK, 4/D | 1 0.01 97.28 UNK, AS NEEDED | 5 0.05 97.33 UNK, AS REQ'D | 2 0.02 97.35 UNK, BID | 6 0.06 97.41 UNK, DAILY (1/D) | 8 0.08 97.49 UNK, DAYS 1+15 | 1 0.01 97.50 UNK, EACH EVENING | 2 0.02 97.52 UNK, HS | 1 0.01 97.53 UNK, ONCE/SINGLE | 3 0.03 97.56 UNK, ORAL | 1 0.01 97.57 UNK, OTHER | 1 0.01 97.58 UNK, PRN | 6 0.06 97.64 UNK, PRN, QHS | 1 0.01 97.65 UNK, Q3W | 10 0.10 97.75 UNK, QAM | 1 0.01 97.76 UNK, QD | 22 0.22 97.98 UNK, QHS | 5 0.05 98.03 UNK, QMO | 1 0.01 98.04 UNK, QW | 1 0.01 98.05 UNK, SC | 1 0.01 98.06 UNK, SINGLE | 3 0.03 98.09 UNK, UNK | 63 0.63 98.72 UNK, UNKNOWN | 31 0.31 99.03 UNK,QHS,IN THE EVENING | 1 0.01 99.04 UNK,UNK | 4 0.04 99.08 UNK; PO | 1 0.01 99.09 UNKNOWN | 65 0.65 99.74 UNKNOWN DOSE ONCE DAILY | 1 0.01 99.75 UNKNOWN OVERDOSE | 1 0.01 99.76 UNSPESIFIED | 1 0.01 99.77 WEEK 0 | 1 0.01 99.78 WEEK 14 | 1 0.01 99.79 WEEK 2 | 1 0.01 99.80 WEEK 22 | 1 0.01 99.81 WEEK 30 | 1 0.01 99.82 WEEK 38 | 1 0.01 99.83 WEEK 46 | 1 0.01 99.84 WEEK 6 | 1 0.01 99.85 WITH SLIGHT EXERTION THE OXYGEN LEVEL.. | 1 0.01 99.86 X1; ICER | 5 0.05 99.91 ^1X/DLA^ | 1 0.01 99.92 ^DF^ | 5 0.05 99.97 ^DF^ FREQUENCY UNKNOWN | 1 0.01 99.98 ^OCCASIONAL^ | 1 0.01 99.99 }150 ML ONCE INTRA-ARTER | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015